NVAX NOVAVAX INC Expansion Plans 8-K Filing 2025 - Investor Update On March 4, 2025, Novavax will update investors at the TD Cowen Health Care Conference about its business strategies and COVID-19 vaccine commercialization plans, including a transition of responsibilities to Sanofi.Get access to all SEC 8-K filings of the NOVAVAX INC